Chronic kidney disease after nonrenal solid organ transplantation: A histological assessment and utility of chronic allograft damage index scoring

Transplantation

Volumn 93, Issue 4, 2012, Pages 406-411

  Kubal, Chandrashekhar ^a,c   Cockwell, Paul ^a,b   Gunson, Bridget ^a   Jesky, Mark ^a,b   Hanvesakul, Rajesh ^a,b   Dronavalli, Vamsidhar ^a   Bonser, Robert S ^a   Neil, Desley ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcineurin inhibitor nephrotoxicity; Chronic kidney disease; Hypertension; Liver transplantation; Renal biopsy

Indexed keywords

CREATININE;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; CHRONIC ALLOGRAFT DAMAGE INDEX; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ARTERIOLES; BIOPSY; CALCINEURIN; CHRONIC DISEASE; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; HYALIN; KIDNEY; KIDNEY DISEASES; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS;

EID: 84857048501     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318240e984     Document Type: Article

References (21)

1. Fisher NC, Nightingale PG, Gunson BK, et al. Chronic renal failure following liver transplantation: A retrospective analysis. Transplantation 1998; 66: 59.
2. Satchithananda DK, Parameshwar J, Sharples L, et al. The incidence of end-stage renal failure in 17 years of heart transplantation: A single center experience. J Heart Lung Transplant 2002; 21: 651.
3. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931.
4. Moreno JM, Cuervas-Mons V, Rubio E, et al. Chronic renal dysfunction after liver transplantation in adult patients: Prevalence, risk factors, and impact on mortality. Transplant Proc 2003; 35: 1907.
5. Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol 2007; 27: 498.
6. Stewart SF, Hudson M, Talbot D, et al. Mycophenolate mofetil monotherapy in liver transplantation. Lancet 2001; 357: 609.
7. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481.
8. Schwarz A, Haller H, Schmitt R, et al. Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transplant 2010; 10: 2017.
9. Kim JY, Akalin E, Dikman S, et al. The variable pathology of kidney disease after liver transplantation. Transplantation 2010; 89: 215.
10. Pillebout E, Nochy D, Hill G, et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005; 5: 1120.
11. Doucette KE, Pang XL, Jackson K, et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 2008; 85: 1733.
12. Limaye AP, Smith KD, Cook L, et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 2005; 5: 614.
13. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007; 27: 195.
14. Hayry P, Paavonen T, Taskinen E, et al. Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for long-term graft survival. Transplant Proc 2004; 36: 89.
15. Isoniemi H, Taskinen E, Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195.
16. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007; 7: 518.
17. Herlenius G, Felldin M, Norden G, et al. Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: Results of a prospective randomized trial. Transplant Proc 2010; 42: 4441.
18. Curtis JJ, Luke RG, Dubovsky E, et al. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986; 2: 477.
19. Pham SM, Kormos RL, Hattler BG, et al. A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results. J Thorac Cardiovasc Surg 1996; 111: 764.
20. Howie AJ, Ferreira MA, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001; 16: 1163.
21. Eardley KS, Kubal C, Zehnder D, et al. The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 2008; 74: 495.